Human Cell Derived Xenograft (CDX) Tumor Models
GemPharmatech has developed a large source of human PDX and CDX (cell derived xenograft) tumor models to support our effort in preclinical testing of novel anti-tumor therapeutics. For this purpose, these xenografts are indispensable and complementary components with our novel immunodeficient mouse models.
Xenograft is a tissue graft or organ transplant from a donor of a different species from the recipient. When using mouse models for the study of human diseases, the most common type of xenograft is the transfer of human tissue, including cells, biopsies or the entire organ to a mouse recipient. To study GvHD (graph vs host disease), healthy tissues from the human donor are xenografted onto a healthy immunocompetent mouse recipient. To study the preclinical efficacy or safety of a candidate drug in treating a human disease, patient or diseased human tissue is xenografted onto a mouse recipient. In order to sustain the xenografted human tissue, GvHD needs to be avoided as much as possible. For this purpose, immunodeficient mice are required. Such strains include spontaneous mutant strains such as nude, scid, NOD, NOD-scid, and genetically engineered strains including loss of function mutations of Rag1, Rag2, Il2rg, B2m, HLA and their various combinations.
Figure 1. Quantity of available human CDX tumor models are indicated by the numbers within each individual slice of the pie.